Advantage Solutions Inc. reported its fourth-quarter and full-year 2024 earnings, revealing a mixed financial performance. The company experienced a slight decline in Q4 revenue, while adjusted ...

Macrophages play a central role in initiating, maintaining, and terminating inflammation. For that, macrophages respond to various external stimuli in changing environments through signaling pathways ...

This month's cover highlights the article Nup358 restricts ER-mitochondria connectivity by modulating mTORC2/Akt/GSK3β signalling by Joseph, Misha Kalarikkal and colleagues. The image shows a human ...

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model based on the published strategy of ...

Against this backdrop, investors have an opportunity to invest in stable robotics stocks, Stryker Corporation (SYK), Fanuc Corporation (FANUY), and UiPath Inc. (PATH), which are at the forefront of ...

The Centers for Disease Control and Prevention is halting promotions it developed for a variety of vaccines. “The Department of Health and Human Services’ assistant secretary for public ...

For anyone who wants to understand Stryker's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit was reduced by US$1.3b due to unusual ...

Stryker Corporation’s SYK shares closed the trading session at $385.18 on Friday, 5.2% below its 52-week high of $406.19 reached on Jan. 28, 2025. In the past six months, SYK has gained 13%.

Below is Validea's guru fundamental report for STRYKER CORP (SYK). Of the 22 guru strategies we follow, SYK rates highest using our P/B Growth Investor model based on the published strategy of ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.